Rolain J M, Maurin M, Raoult D
Unité des Rickettsies CNRS UPRES-A 6020, Faculté de Médecine, Université de la Méditerranée, 27 Boulevard Jean Moulin, 13385 Marseille Cedex 05, France.
J Antimicrob Chemother. 2000 Nov;46(5):811-4. doi: 10.1093/jac/46.5.811.
The species Bartonella and Brucella are phylogenetically closely related bacteria, both of which can produce chronic infections in humans that are difficult to cure with antibiotics. MICs of antibiotics for both species correlate poorly with the in vivo efficacy of the antibiotics. In this study we have determined MBCs of several antibiotics for this group of pathogens. Only the aminoglycosides were bactericidal, and this correlates well with the usefulness of these antibiotics for the therapy of human brucellosis and chronic Bartonella spp. infections such as endocarditis. Our data indicate that current clinical experience in treating brucellosis may help to define better the optimum antibiotic therapy for Bartonella-related diseases.
巴尔通体属和布鲁氏菌属是系统发育上密切相关的细菌,二者均可在人类中引发慢性感染,且这些感染难以用抗生素治愈。这两种细菌对抗生素的最低抑菌浓度(MIC)与抗生素的体内疗效相关性较差。在本研究中,我们测定了几种抗生素对这组病原体的最低杀菌浓度(MBC)。只有氨基糖苷类具有杀菌作用,这与这些抗生素在治疗人类布鲁氏菌病和慢性巴尔通体属感染(如心内膜炎)中的效用密切相关。我们的数据表明,目前治疗布鲁氏菌病的临床经验可能有助于更好地确定巴尔通体相关疾病的最佳抗生素治疗方案。